AU2001278684A1 - Protein induced by homogeneous blood transfusion and dna encoding the same - Google Patents

Protein induced by homogeneous blood transfusion and dna encoding the same

Info

Publication number
AU2001278684A1
AU2001278684A1 AU2001278684A AU7868401A AU2001278684A1 AU 2001278684 A1 AU2001278684 A1 AU 2001278684A1 AU 2001278684 A AU2001278684 A AU 2001278684A AU 7868401 A AU7868401 A AU 7868401A AU 2001278684 A1 AU2001278684 A1 AU 2001278684A1
Authority
AU
Australia
Prior art keywords
protein
same
dna encoding
blood transfusion
protein induced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278684A
Inventor
Akio Fujimura
Yasuhiko Kitoh
Eiji Kobayashi
Hirokazu Tanaka
Hiroo Uchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruho Co Ltd
Original Assignee
Maruho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruho Co Ltd filed Critical Maruho Co Ltd
Publication of AU2001278684A1 publication Critical patent/AU2001278684A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to a novel protein (MAY-I) which exhibits immunosuppressive activity in allogeneic mixed lymphocyte reaction, and provides a gene encoding that protein, a vector containing said gene, a transformant produced by said vector, a method of manufacturing the said protein with immune activity by culturing said transformant, and a medicinal composition and the like containing the said protein.
AU2001278684A 2000-08-09 2001-08-01 Protein induced by homogeneous blood transfusion and dna encoding the same Abandoned AU2001278684A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000241169 2000-08-09
JP2000-241169 2000-08-09
PCT/JP2001/006620 WO2002012495A1 (en) 2000-08-09 2001-08-01 Protein induced by homogeneous blood transfusion and dna encoding the same

Publications (1)

Publication Number Publication Date
AU2001278684A1 true AU2001278684A1 (en) 2002-02-18

Family

ID=18732399

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278684A Abandoned AU2001278684A1 (en) 2000-08-09 2001-08-01 Protein induced by homogeneous blood transfusion and dna encoding the same

Country Status (8)

Country Link
US (1) US7091316B2 (en)
EP (1) EP1312675B1 (en)
JP (1) JP4683819B2 (en)
AT (1) ATE435237T1 (en)
AU (1) AU2001278684A1 (en)
CA (1) CA2418395C (en)
DE (1) DE60139131D1 (en)
WO (1) WO2002012495A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009013292A (en) 2007-06-12 2010-01-25 Kinetic Spine Technologies Inc Artificial intervertebral disc.
KR20100058496A (en) * 2007-07-20 2010-06-03 더 유니버시티 오브 유타 리서치 파운데이션 Identification and quantification of biomarkers for evaluating the risk of preterm birth
BR112017027528A2 (en) 2015-06-19 2018-09-11 Sera Prognostics, Inc. composition, panel, method for determining the likelihood of preterm birth in a pregnant female and method of detecting ibp4 and shbg in a pregnant female?
CA3073192A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc Pregnancy clock proteins for predicting due date and time to birth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459063A (en) * 1993-10-14 1995-10-17 The University Of Pennsylvania Plasmodium falciparum ribonucleotide reductase DNA
US5919902A (en) * 1996-06-07 1999-07-06 Eli Lilly And Company Leptin bound to inter-alphatrypsin inhibitor and uses thereof
KR100523199B1 (en) * 1997-03-31 2005-10-21 알자 코포레이션 Diffusional implantable delivery system and method thereof, and method for preparing the system
EP1037979A2 (en) * 1997-12-03 2000-09-27 Genentech, Inc. Polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
EP1312675A1 (en) 2003-05-21
US20050049189A1 (en) 2005-03-03
EP1312675A4 (en) 2004-07-14
CA2418395A1 (en) 2002-02-14
EP1312675B1 (en) 2009-07-01
ATE435237T1 (en) 2009-07-15
DE60139131D1 (en) 2009-08-13
JP4683819B2 (en) 2011-05-18
US7091316B2 (en) 2006-08-15
WO2002012495A1 (en) 2002-02-14
CA2418395C (en) 2010-05-04

Similar Documents

Publication Publication Date Title
WO1993016099A3 (en) Dna sequences encoding novel growth/differentiation factors
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
AU4981101A (en) Subtilisin variants
TW373023B (en) Production of antibodies
MY162525A (en) Process for concentration of antibodies and therapeutic products thereof
MXPA03005273A (en) Prokaryotically produced antibodies and uses thereof.
ATE377076T1 (en) HUMAN CYTOKINE AS A LIGAND OF THE ZALPHA RECEPTOR AND ITS USES
WO2003020932A1 (en) Novel secretory proteins and dna thereof
MXPA03007563A (en) Increased recovery of active proteins.
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
IL85878A0 (en) Anticoagulant proteins,dna coding for them,processes for preparing them,pharmaceutical compositions containing them,monoclonal antibodies against such proteins and hybrid cell lines which secrete these antibodies
WO1997020933A3 (en) Mutational variants of mammalian ob gene proteins
EP0232523A3 (en) Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
EP0754229A1 (en) Alfamin: a human serum albumin-like protein
AU2001278684A1 (en) Protein induced by homogeneous blood transfusion and dna encoding the same
AU6724794A (en) GRB3-3 gene, its variants and their uses
SI1465927T1 (en) Bag3 antibodies to be used in research, diagnostics and therapy for cell death-involving diseases
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
IL177179A (en) Fusion protein comprising truncated n-acetylgalactosaminyltransferase 2 (galnact2) and maltose binding domain
HK1021983A1 (en) Protein participating in activation of nitrile hy dratase and gene encoding the same
EP0990703A4 (en) Novel polypeptide, dna encoding the same and use thereof
AU7508694A (en) Novel tyrosine kinase
WO2003093298A3 (en) Immunogenic peptides
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof